Travere Therapeutics, Inc. (TVTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -40.37M | 60.68M | 14.32M | 4.98M | -42.19M | -35.72M | -42.51M | -40.24M | -119M | -70.47M | -59.13M | -69.3M | -81.12M | -54.64M | -39.52M | -36.81M | -55.32M | -26.88M | 32.06M | 6.5M |
| Operating CF Margin % | -31.73% | 46.79% | 8.68% | 4.35% | -51.62% | -47.76% | -67.58% | -74.36% | -287.63% | -156.4% | -159.41% | -215.23% | -142.33% | -97.8% | -140.78% | -67.95% | -114.09% | -46.95% | 47% | 11.89% |
| Operating CF Growth % | 4.33% | 269.87% | 133.68% | 112.38% | 64.54% | 49.31% | 28.12% | 41.93% | -46.71% | -28.98% | -49.61% | -88.28% | -46.63% | -103.3% | -223.27% | -666.59% | -108.96% | -93.78% | 376.07% | 200.67% |
| Net Income | -36.6M | -21.99M | 25.71M | -12.76M | -41.23M | -60.27M | -54.75M | -69.65M | -136.06M | -88.6M | -89.24M | -85.63M | -86.33M | -85.64M | -84.06M | -67.03M | -75.97M | -51.57M | -35.64M | -39.01M |
| Depreciation & Amortization | 25.21M | 18.14M | 15.79M | 14.02M | 12.8M | 12.09M | 11.24M | 10.35M | 9.88M | 11.85M | 11.47M | 13.9M | 9.54M | 9.3M | 6.15M | 8.11M | 7.09M | 6.05M | 7.87M | 6.62M |
| Stock-Based Compensation | 16.15M | 0 | 11.26M | 10.65M | 11.49M | 9.21M | 8.02M | 9.92M | 9.76M | 8.14M | 0 | 11.9M | 13.47M | 0 | 0 | 12.64M | 8.19M | 8.58M | 6.99M | 7.3M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -109.42M | 0 | -3.33M | 0 | 0 | 0 | 0 | 0 | 1.44M | 0 | 170K |
| Other Non-Cash Items | -4K | 11.86M | -1.11M | -1.29M | -1.57M | -4.16M | -278K | 69.88M | 364K | 100.45M | 22.19M | 1.09M | 3.98M | 25.98M | 25.89M | 5.5M | 16.7M | -6.54M | 16.84M | 4.27M |
| Working Capital Changes | -45.12M | 52.67M | -37.33M | -5.64M | -23.69M | 7.4M | -6.74M | -60.74M | -2.95M | 7.1M | -3.56M | -6.94M | -22.07M | -4.28M | 12.5M | 3.98M | -11.32M | 15.17M | 36.01M | 27.15M |
| Change in Receivables | -7.22M | 27.82M | -44.16M | -4.28M | -7.2M | -2.02M | -731K | -1.74M | -1.55M | -7.97M | 440K | 1.16M | -4.89M | -6.38M | 5.85M | -2.15M | 1.24M | -2.64M | -1.48M | 1.21M |
| Change in Inventory | -742K | 1.18M | 194K | -19K | 3.66M | -285K | -246K | -1.42M | -1.82M | -22.39M | -4M | -12.51M | -513K | 38K | 813K | 0 | 949K | -1.44M | 384K | -701K |
| Change in Payables | -11.81M | 6.25M | -1.11M | 3.08M | -8.3M | 1.01M | -2.93M | 9.2M | -24.84M | 17.3M | 4.96M | 3.14M | -627K | 2.25M | 2.72M | 1.69M | -4.61M | 862K | -2.77M | 24.92M |
| Cash from Investing | 21.55M | -104.84M | 86.59M | 4.85M | 41.29M | -80.31M | 46.13M | 28.61M | 104.9M | -16.95M | 133.32M | -23.55M | -37.04M | -36.7M | 10.08M | -39.1M | 33.16M | 7.37M | 32.52M | -71.81M |
| Capital Expenditures | -22.18M | -18.86M | -15.19M | -235K | 0 | -9.56M | 18.38M | -11.99M | -6.47M | -5.53M | -4.93M | -3.2M | -27.97M | -4.2M | -7.63M | -11.46M | -5.27M | -5.2M | -5.37M | -4.31M |
| CapEx % of Revenue | 17.44% | 14.55% | 9.21% | 0.21% | 14.42% | 12.78% | 29.22% | 22.16% | 15.63% | 12.27% | 13.28% | 9.95% | 49.07% | 7.51% | 27.19% | 21.16% | 10.86% | 9.08% | 7.88% | 7.89% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.65M | 0 | 3.2M | 27.34M | 0 | 0 | 0 | 5.14M | 14M | 0 | 4.2M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -470K | 3K | -11.94M | -11.87M | -40K | -26.57M | -65M | 0 | -11.42M | 206.17M | -3.84M | -27.34M | -600K | 0 | 0 | -5.14M | -14M | 0 | -4.2M |
| Cash from Financing | 4.2M | 26.68M | -65.34M | 1.48M | 3.72M | 139.12M | 46K | 782K | -525K | 124K | -634K | 2.27M | 217M | 551K | 2.28M | 831K | 113.91M | 33.21M | 2.41M | 303K |
| Debt Issued (Net) | 0 | 0 | -68.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -394K | 95.44M | 0 | 0 | 0 |
| Equity Issued (Net) | 4.73M | 27.2M | 4.09M | 2M | 4.24M | 139.64M | 571K | 1.31M | 0 | 908K | 151K | -1K | 191.2M | 1.68M | 3.41M | 2.35M | 19.55M | 30.78M | 3.6M | -99K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -525K | -525K | -525K | -525K | -525K | -525K | -525K | -525K | -525K | -784K | -785K | 2.27M | 25.8M | -1.13M | -1.13M | -1.13M | -1.07M | 2.44M | -1.19M | 402K |
| Net Change in Cash | -14.67M | -17.89M | 35.78M | 13.26M | 3.36M | 22.13M | 4.12M | -10.96M | -14.93M | -86.07M | 73.37M | -90.5M | 99.69M | -89.65M | -28.42M | -76.81M | 90.82M | 15.43M | 67.04M | -64.94M |
| Free Cash Flow | -62.54M | 61.05M | 14.18M | 4.75M | -53.98M | -45.28M | -50.7M | -52.24M | -125.47M | -76M | -59.14M | -72.5M | -109.08M | -54.67M | -39.54M | -36.82M | -60.59M | -32.08M | 31.71M | 2.19M |
| FCF Margin % | -49.17% | 47.08% | 8.6% | 4.15% | -66.04% | -60.55% | -80.61% | -96.53% | -303.26% | -168.67% | -159.44% | -225.18% | -191.4% | -97.86% | -140.83% | -67.98% | -124.96% | -56.03% | 46.49% | 4.01% |
| FCF Growth % | -15.87% | 234.83% | 127.96% | 109.09% | 56.98% | 40.42% | 14.28% | 27.95% | -15.02% | -39.02% | -49.59% | -96.89% | -80.05% | -70.43% | -224.67% | -1782.18% | -69.5% | 72.76% | 17718.89% | 120.1% |
| FCF per Share | -0.68 | 0.68 | 0.14 | 0.05 | -0.61 | -0.54 | -0.65 | -0.67 | -1.63 | -0.99 | -0.78 | -0.95 | -1.60 | -0.85 | -0.62 | -0.58 | -0.96 | -0.52 | 0.52 | 0.04 |
| FCF Conversion (FCF/Net Income) | 1.09x | 22.23x | 0.56x | -0.39x | 1.02x | 0.59x | 0.78x | 0.57x | 0.87x | 0.78x | -0.39x | 0.81x | 0.94x | 0.83x | 0.57x | 0.55x | 0.73x | 0.52x | -0.90x | -0.17x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |